To Develop, Implement and Evaluate the Polio Demonstration Project Comprising of a Community Based Intervention Package for Polio Eradication in Pakistan

NCT01908114 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60000

Last updated 2021-02-18

No results posted yet for this study

Summary

The objective of the projects is to Develop and implement a Package of interventions that will comprise of an augmented communication and counseling strategy coupled with private sector involvement and a combined Oral Polio Vaccine and Inject able Polio Vaccine approach during the Polio campaigns followed by the evaluation of this project for acceptability, feasibility and effectiveness of the intervention Package.

Conditions

  • Polio
  • Polio Sero Conversion
  • Polio Sero Prevalence
  • Immunization Coverage

Interventions

BEHAVIORAL

Enhanced Community mobilization

BIOLOGICAL

Combined Oral Polio Vaccine and Inject able Polio Vaccine during SIA

Sponsors & Collaborators

  • Pakistan Ministry of Health

    collaborator OTHER_GOV
  • Trust for Vaccines and Immunization, Pakistan

    collaborator OTHER
  • National Institutes of Health, Pakistan

    collaborator OTHER
  • Peshawar Medical College

    collaborator OTHER
  • World Health Organization

    collaborator OTHER
  • UNICEF

    collaborator OTHER
  • Bill and Melinda Gates Foundation

    collaborator OTHER
  • Aga Khan University

    lead OTHER

Principal Investigators

  • Zulfiqar A Bhutta, PhD · Aga Khan University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
FACTORIAL

Eligibility

Min Age
1 Month
Max Age
5 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-07-31
Primary Completion
2017-07-31
Completion
2021-12-31

Countries

  • Pakistan

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01908114 on ClinicalTrials.gov